Medical Care
Global mRNA Cancer Vaccines and Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 223281
- Pages: 79
- Figures: 76
- Views: 43
The global mRNA Cancer Vaccines and Therapeutics market size was US$ 198 million in 2024 and is forecast to a readjusted size of US$ 659 million by 2031 with a CAGR of 19.0% during the forecast period 2025-2031.
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
The global mRNA Cancer Vaccines and Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
By Application: (Core Demand Driver vs Emerging Opportunity)
Infectious Disease
Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Moderna Therapeutics in Europe)
- Emerging Product Trends: Adeno Carcinomas adoption vs. Mucinous Carcinomas premiumization
- Demand-Side Dynamics: Infectious Disease growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of mRNA Cancer Vaccines and Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mucinous Carcinomas in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the mRNA Cancer Vaccines and Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
North America is the largest mRNA Cancer Vaccines and Therapeutics market with about 69% market share. Europe is follower, accounting for about 28% market share.
The key players are Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. Top 3 companies occupied about 82% market share.
The global mRNA Cancer Vaccines and Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
Adeno Carcinomas
Mucinous Carcinomas
Adenosquamous Carcinomas
By Application: (Core Demand Driver vs Emerging Opportunity)
Infectious Disease
Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Moderna Therapeutics in Europe)
- Emerging Product Trends: Adeno Carcinomas adoption vs. Mucinous Carcinomas premiumization
- Demand-Side Dynamics: Infectious Disease growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of mRNA Cancer Vaccines and Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Mucinous Carcinomas in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the mRNA Cancer Vaccines and Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types mRNA Cancer Vaccines and Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in mRNA Cancer Vaccines and Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2020-2025)
5.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
5.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Analysis
5.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
5.5 Global Key Players of mRNA Cancer Vaccines and Therapeutics Head office and Area Served
5.6 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
5.7 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Details
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
7.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.1.5 Moderna Therapeutics Recent Development
7.2 CureVac
7.2.1 CureVac Company Details
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
7.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.2.5 CureVac Recent Development
7.3 Translate Bio
7.3.1 Translate Bio Company Details
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
7.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.3.5 Translate Bio Recent Development
7.4 BioNTech
7.4.1 BioNTech Company Details
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
7.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.4.5 BioNTech Recent Development
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Details
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
7.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.5.5 Sangamo Therapeutics Recent Development
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Details
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
7.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.6.5 Argos Therapeutics Recent Development
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Details
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
7.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.7.5 In-Cell-Art Recent Development
7.8 eTheRNA
7.8.1 eTheRNA Company Details
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
7.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.8.5 eTheRNA Recent Development
7.9 Ethris
7.9.1 Ethris Company Details
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
7.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.9.5 Ethris Recent Development
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Details
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
7.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.10.5 Tiba Biotechnology Recent Development
8 mRNA Cancer Vaccines and Therapeutics Market Dynamics
8.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
8.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
8.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
8.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Adeno Carcinomas
1.2.3 Mucinous Carcinomas
1.2.4 Adenosquamous Carcinomas
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Cancer Vaccines and Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America mRNA Cancer Vaccines and Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types mRNA Cancer Vaccines and Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global mRNA Cancer Vaccines and Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in mRNA Cancer Vaccines and Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top mRNA Cancer Vaccines and Therapeutics Players by Revenue (2020-2025)
5.1.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by mRNA Cancer Vaccines and Therapeutics Revenue
5.4 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Analysis
5.4.1 Global mRNA Cancer Vaccines and Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
5.5 Global Key Players of mRNA Cancer Vaccines and Therapeutics Head office and Area Served
5.6 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
5.7 Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 Moderna Therapeutics
7.1.1 Moderna Therapeutics Company Details
7.1.2 Moderna Therapeutics Business Overview
7.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
7.1.4 Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.1.5 Moderna Therapeutics Recent Development
7.2 CureVac
7.2.1 CureVac Company Details
7.2.2 CureVac Business Overview
7.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Introduction
7.2.4 CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.2.5 CureVac Recent Development
7.3 Translate Bio
7.3.1 Translate Bio Company Details
7.3.2 Translate Bio Business Overview
7.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Introduction
7.3.4 Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.3.5 Translate Bio Recent Development
7.4 BioNTech
7.4.1 BioNTech Company Details
7.4.2 BioNTech Business Overview
7.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Introduction
7.4.4 BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.4.5 BioNTech Recent Development
7.5 Sangamo Therapeutics
7.5.1 Sangamo Therapeutics Company Details
7.5.2 Sangamo Therapeutics Business Overview
7.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
7.5.4 Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.5.5 Sangamo Therapeutics Recent Development
7.6 Argos Therapeutics
7.6.1 Argos Therapeutics Company Details
7.6.2 Argos Therapeutics Business Overview
7.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Introduction
7.6.4 Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.6.5 Argos Therapeutics Recent Development
7.7 In-Cell-Art
7.7.1 In-Cell-Art Company Details
7.7.2 In-Cell-Art Business Overview
7.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Introduction
7.7.4 In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.7.5 In-Cell-Art Recent Development
7.8 eTheRNA
7.8.1 eTheRNA Company Details
7.8.2 eTheRNA Business Overview
7.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Introduction
7.8.4 eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.8.5 eTheRNA Recent Development
7.9 Ethris
7.9.1 Ethris Company Details
7.9.2 Ethris Business Overview
7.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Introduction
7.9.4 Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.9.5 Ethris Recent Development
7.10 Tiba Biotechnology
7.10.1 Tiba Biotechnology Company Details
7.10.2 Tiba Biotechnology Business Overview
7.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Introduction
7.10.4 Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
7.10.5 Tiba Biotechnology Recent Development
8 mRNA Cancer Vaccines and Therapeutics Market Dynamics
8.1 mRNA Cancer Vaccines and Therapeutics Industry Trends
8.2 mRNA Cancer Vaccines and Therapeutics Market Drivers
8.3 mRNA Cancer Vaccines and Therapeutics Market Challenges
8.4 mRNA Cancer Vaccines and Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global mRNA Cancer Vaccines and Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in mRNA Cancer Vaccines and Therapeutics Application
Table 18. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Table 21. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
Table 25. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. Moderna Therapeutics Company Details
Table 36. Moderna Therapeutics Business Overview
Table 37. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 38. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 39. Moderna Therapeutics Recent Development
Table 40. CureVac Company Details
Table 41. CureVac Business Overview
Table 42. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 43. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 44. CureVac Recent Development
Table 45. Translate Bio Company Details
Table 46. Translate Bio Business Overview
Table 47. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 48. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 49. Translate Bio Recent Development
Table 50. BioNTech Company Details
Table 51. BioNTech Business Overview
Table 52. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 53. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 54. BioNTech Recent Development
Table 55. Sangamo Therapeutics Company Details
Table 56. Sangamo Therapeutics Business Overview
Table 57. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 58. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 59. Sangamo Therapeutics Recent Development
Table 60. Argos Therapeutics Company Details
Table 61. Argos Therapeutics Business Overview
Table 62. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 63. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 64. Argos Therapeutics Recent Development
Table 65. In-Cell-Art Company Details
Table 66. In-Cell-Art Business Overview
Table 67. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 68. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 69. In-Cell-Art Recent Development
Table 70. eTheRNA Company Details
Table 71. eTheRNA Business Overview
Table 72. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 73. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 74. eTheRNA Recent Development
Table 75. Ethris Company Details
Table 76. Ethris Business Overview
Table 77. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 78. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 79. Ethris Recent Development
Table 80. Tiba Biotechnology Company Details
Table 81. Tiba Biotechnology Business Overview
Table 82. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 83. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 84. Tiba Biotechnology Recent Development
Table 85. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 86. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 87. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 88. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Product Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Adeno Carcinomas Features
Figure 4. Mucinous Carcinomas Features
Figure 5. Adenosquamous Carcinomas Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Infectious Disease
Figure 8. Cancer
Figure 9. Others
Figure 10. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2024
Figure 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
Figure 21. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
Figure 22. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
Figure 23. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 24. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 25. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 26. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 27. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 28. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 29. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 30. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 31. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 32. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed
Table 1. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global mRNA Cancer Vaccines and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global mRNA Cancer Vaccines and Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global mRNA Cancer Vaccines and Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in mRNA Cancer Vaccines and Therapeutics Application
Table 18. Global mRNA Cancer Vaccines and Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Table 21. Ranking of Global Top mRNA Cancer Vaccines and Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Product and Application
Table 25. Global Key Players of mRNA Cancer Vaccines and Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe mRNA Cancer Vaccines and Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. Moderna Therapeutics Company Details
Table 36. Moderna Therapeutics Business Overview
Table 37. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 38. Moderna Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 39. Moderna Therapeutics Recent Development
Table 40. CureVac Company Details
Table 41. CureVac Business Overview
Table 42. CureVac mRNA Cancer Vaccines and Therapeutics Product
Table 43. CureVac Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 44. CureVac Recent Development
Table 45. Translate Bio Company Details
Table 46. Translate Bio Business Overview
Table 47. Translate Bio mRNA Cancer Vaccines and Therapeutics Product
Table 48. Translate Bio Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 49. Translate Bio Recent Development
Table 50. BioNTech Company Details
Table 51. BioNTech Business Overview
Table 52. BioNTech mRNA Cancer Vaccines and Therapeutics Product
Table 53. BioNTech Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 54. BioNTech Recent Development
Table 55. Sangamo Therapeutics Company Details
Table 56. Sangamo Therapeutics Business Overview
Table 57. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 58. Sangamo Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 59. Sangamo Therapeutics Recent Development
Table 60. Argos Therapeutics Company Details
Table 61. Argos Therapeutics Business Overview
Table 62. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product
Table 63. Argos Therapeutics Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 64. Argos Therapeutics Recent Development
Table 65. In-Cell-Art Company Details
Table 66. In-Cell-Art Business Overview
Table 67. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product
Table 68. In-Cell-Art Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 69. In-Cell-Art Recent Development
Table 70. eTheRNA Company Details
Table 71. eTheRNA Business Overview
Table 72. eTheRNA mRNA Cancer Vaccines and Therapeutics Product
Table 73. eTheRNA Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 74. eTheRNA Recent Development
Table 75. Ethris Company Details
Table 76. Ethris Business Overview
Table 77. Ethris mRNA Cancer Vaccines and Therapeutics Product
Table 78. Ethris Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 79. Ethris Recent Development
Table 80. Tiba Biotechnology Company Details
Table 81. Tiba Biotechnology Business Overview
Table 82. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product
Table 83. Tiba Biotechnology Revenue in mRNA Cancer Vaccines and Therapeutics Business (2020-2025) & (US$ Million)
Table 84. Tiba Biotechnology Recent Development
Table 85. mRNA Cancer Vaccines and Therapeutics Market Trends
Table 86. mRNA Cancer Vaccines and Therapeutics Market Drivers
Table 87. mRNA Cancer Vaccines and Therapeutics Market Challenges
Table 88. mRNA Cancer Vaccines and Therapeutics Market Restraints
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. mRNA Cancer Vaccines and Therapeutics Product Picture
Figure 2. Global mRNA Cancer Vaccines and Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Adeno Carcinomas Features
Figure 4. Mucinous Carcinomas Features
Figure 5. Adenosquamous Carcinomas Features
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Market Share by Application: 2024 VS 2031
Figure 7. Infectious Disease
Figure 8. Cancer
Figure 9. Others
Figure 10. mRNA Cancer Vaccines and Therapeutics Report Years Considered
Figure 11. Global mRNA Cancer Vaccines and Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global mRNA Cancer Vaccines and Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe mRNA Cancer Vaccines and Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Global mRNA Cancer Vaccines and Therapeutics Market Share by Players in 2024
Figure 17. Global Top mRNA Cancer Vaccines and Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Cancer Vaccines and Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2024
Figure 19. North America mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
Figure 20. North America mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
Figure 21. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Type (2020-2025)
Figure 22. Europe mRNA Cancer Vaccines and Therapeutics Market Share by Application (2020-2025)
Figure 23. Moderna Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 24. CureVac Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 25. Translate Bio Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 26. BioNTech Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 27. Sangamo Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 28. Argos Therapeutics Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 29. In-Cell-Art Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 30. eTheRNA Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 31. Ethris Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 32. Tiba Biotechnology Revenue Growth Rate in mRNA Cancer Vaccines and Therapeutics Business (2020-2025)
Figure 33. Bottom-up and Top-down Approaches for This Report
Figure 34. Data Triangulation
Figure 35. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232